Patrick A. Mcbrayer Buys 1,000 Shares of Misonix, Inc. (MSON) Stock
Misonix, Inc. (NASDAQ:MSON) Director Patrick A. Mcbrayer bought 1,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was purchased at an average price of $10.54 per share, with a total value of $10,540.00. Following the completion of the purchase, the director now owns 1,100 shares in the company, valued at $11,594. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
Misonix, Inc. (MSON) traded up $0.30 during trading hours on Monday, reaching $10.40. 15,800 shares of the company’s stock were exchanged, compared to its average volume of 9,134. Misonix, Inc. has a 52 week low of $7.05 and a 52 week high of $12.00.
Large investors have recently bought and sold shares of the business. Keybank National Association OH acquired a new position in Misonix during the fourth quarter worth $109,000. Northern Trust Corp raised its position in shares of Misonix by 2.5% in the second quarter. Northern Trust Corp now owns 24,378 shares of the medical equipment provider’s stock valued at $233,000 after buying an additional 591 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Misonix by 0.9% in the second quarter. Vanguard Group Inc. now owns 106,353 shares of the medical equipment provider’s stock valued at $1,027,000 after buying an additional 900 shares during the last quarter. Institutional investors own 10.34% of the company’s stock.
Misonix, Inc designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company’s products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties.
Receive News & Ratings for Misonix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Misonix and related companies with MarketBeat.com's FREE daily email newsletter.